Tag

#endocrinology

5 studies

Weight LossAug 26, 2026
RCT·The New England journal of medicine

Novel Dual-Action Weekly Injection Successfully Redefines Obesity Treatment

A new phase 3 clinical trial reveals that survodutide, a weekly dual-agonist injection, helps adults achieve significant weight reduction.

Read Analysis
Weight LossAug 19, 2026
RCT·The lancet. Diabetes & endocrinology

Dual-Drug Therapy Outperforms Semaglutide Alone for Weight Loss

A combination of cagrilintide and semaglutide helped patients lose significantly more weight than semaglutide alone in a new clinical trial.

Read Analysis
Weight LossAug 12, 2026
RCT·The lancet. Diabetes & endocrinology

New Duo Drug CagriSema Shows Dramatic Results for Diabetes

A dual-action weekly injection called CagriSema drastically lowers blood sugar and body weight in adults with early-stage type 2 diabetes.

Read Analysis
Weight LossJul 22, 2026
RCT·The lancet. Diabetes & endocrinology

New Dual-Action Drug Outperforms Semaglutide in Diabetes Trial

A new combination therapy called CagriSema shows superior blood sugar control compared to semaglutide alone in a major phase 3 clinical trial.

Read Analysis
SupplementsMay 20, 2026
Review·Nutrients

Unpacking the New Vitamin D Guidelines: Who Needs It?

A recent review critically examines the 2024 Endocrine Society guidelines on vitamin D, highlighting new recommendations and remaining uncertainties.

Read Analysis